Paragon Bioservices Recognized as "Best Contract Manufacturing Organization" by World Vaccine Congress 2016
BALTIMORE, April 5, 2016 /PRNewswire/ -- Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that it was selected as the "Best Contract Manufacturing Organization" by the World Vaccine Congress, at its annual meeting held in Washington, D.C. last week. The Vaccine Industry Excellence (ViE) Awards honor the industry's most outstanding achievements in vaccine development from all corners of the globe. The award in this category was based on consideration of the range of services provided in niche and core therapeutic areas, methods of performance improvement, attention to and quality of relationships with clients, reaching of milestones and outcomes, and building and maintaining long-term partnerships.
Paragon's focus is the development and manufacturing of biopharmaceuticals—including the production and purification of recombinant proteins, viral vectors and vaccines. The company provides research services, process development and cGMP manufacturing. Paragon's cGMP facilities include microbial and mammalian suites, aseptic fill-finish and fully-segregated virus facilities. Paragon functions as a translational bridge—from the research bench through manufacturing of finished drug product for Phase I/II clinical trials. Paragon's aim is to build strong development and manufacturing partnerships with biopharmaceutical clients, focusing on transformative technologies, including oncology immunotherapies (CAR-T cell therapies and oncolytic viruses), new generation vaccines (VLPs) and gene therapies (AAV).
"Credit for this recognition goes, first and foremost, to all of our hard-working scientists, engineers, quality systems personnel and project managers," commented Peter Buzy, President of Paragon Bioservices. "This acknowledgement from our peers is a great honor and we hope that it reflects our dedication and passion for the science," added Mr. Buzy.
About the ViE Awards
The World Vaccine Congress, now in its 16th year, is well-established as the leading event on vaccines in the industry. Covering crucial topics that affect the whole sector—everything from the latest in R&D to manufacturing to corporate development strategies—the Congress hosts the only awards ceremony dedicated to the vaccine industry. The ViE Awards honor individuals, organizations and initiatives that have made significant contributions over the past 12 months to innovation in the field of vaccines.
About Paragon Bioservices, Inc.
Paragon Bioservices is a private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of biopharmaceuticals—including the production and purification of monoclonal antibodies, recombinant proteins, viral vectors and vaccines. The company provides research services, process development and cGMP manufacturing. Paragon's cGMP facilities include microbial and mammalian suites, fill-finish and fully-segregated virus facilities.
Media Contact
Kevin Sly, SVP Marketing & Commercial Strategy
PH (410) 975-4053
Logo - http://photos.prnewswire.com/prnh/20141124/160644LOGO
SOURCE Paragon Bioservices, Inc.
Share this article